At-Home Trial of Four Different Head-Mounted Displays in Visual Rehabilitation of People with Stargardt Disease
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
At-Home Trial of Four Different Head-Mounted Displays in Visual Rehabilitation of People with Stargardt Disease. / Schmidt, Diana Chabané; Kjølholm, Christine Dahlgren Bohnsack; Jordana, Joaquim Torner; Spange, Vibeke; Højstrup, Pernille Duelund; Larsen, Bo Schack; Kessel, Line.
In: Clinical Optometry, Vol. 15, 2023, p. 271-281.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - At-Home Trial of Four Different Head-Mounted Displays in Visual Rehabilitation of People with Stargardt Disease
AU - Schmidt, Diana Chabané
AU - Kjølholm, Christine Dahlgren Bohnsack
AU - Jordana, Joaquim Torner
AU - Spange, Vibeke
AU - Højstrup, Pernille Duelund
AU - Larsen, Bo Schack
AU - Kessel, Line
N1 - Publisher Copyright: © 2023 Schmidt et al.
PY - 2023
Y1 - 2023
N2 - Purpose: To examine the potential of different head-mounted displays in the rehabilitation of individuals with visual impairment. Methods: This prospective explorative study conducted between September 2019 and August 2020 included participants with Stargardt disease with moderate to severe visual impairment and a relatively preserved peripheral visual field. AceSight, eSight 3, IrisVision Live, and Jordy were tested. After instruction and training, participants chose two head-mounted displays for home use for two weeks per device. The Canadian Occupational Performance Measure was used for evaluation. Results: Twelve participants (aged 16–53 years) tested all head-mounted displays in the clinic. Distance visual acuity and reading distance improved with all head-mounted displays and eSight and Irisvision improved near visual acuity. Six participants decided not to test the head-mounted display at home due to lack of time or energy, dizziness and discomfort, double vision and peripheral visual field limitation, or aesthetics. After home use, the participants reported improved visual function at a distance with IrisVision, AceSight, and e-Sight, whereas only AceSight improved vision during near tasks. IrisVision and eSight improved reading ability, and none of the devices improved vision during tasks involving computers. Five participants used the devices sparingly, and five avoided public use owing to aesthetics. Conclusion: We found an improvement in distance visual acuity and increased reading distance for all tested head-mounted displays. Additionally, IrisVision and eSight improved visual function at near and eSight also improved contrast vision at distance. Despite the possibility of improving vision, social stigma and device aesthetics kept the participants from using head-mounted displays in public and limited their use at home.
AB - Purpose: To examine the potential of different head-mounted displays in the rehabilitation of individuals with visual impairment. Methods: This prospective explorative study conducted between September 2019 and August 2020 included participants with Stargardt disease with moderate to severe visual impairment and a relatively preserved peripheral visual field. AceSight, eSight 3, IrisVision Live, and Jordy were tested. After instruction and training, participants chose two head-mounted displays for home use for two weeks per device. The Canadian Occupational Performance Measure was used for evaluation. Results: Twelve participants (aged 16–53 years) tested all head-mounted displays in the clinic. Distance visual acuity and reading distance improved with all head-mounted displays and eSight and Irisvision improved near visual acuity. Six participants decided not to test the head-mounted display at home due to lack of time or energy, dizziness and discomfort, double vision and peripheral visual field limitation, or aesthetics. After home use, the participants reported improved visual function at a distance with IrisVision, AceSight, and e-Sight, whereas only AceSight improved vision during near tasks. IrisVision and eSight improved reading ability, and none of the devices improved vision during tasks involving computers. Five participants used the devices sparingly, and five avoided public use owing to aesthetics. Conclusion: We found an improvement in distance visual acuity and increased reading distance for all tested head-mounted displays. Additionally, IrisVision and eSight improved visual function at near and eSight also improved contrast vision at distance. Despite the possibility of improving vision, social stigma and device aesthetics kept the participants from using head-mounted displays in public and limited their use at home.
KW - electronic glasses
KW - head-mounted display
KW - Stargardt disease
KW - visual aid
KW - visual impairment
U2 - 10.2147/OPTO.S434404
DO - 10.2147/OPTO.S434404
M3 - Journal article
C2 - 38046087
AN - SCOPUS:85178365448
VL - 15
SP - 271
EP - 281
JO - Clinical Optometry
JF - Clinical Optometry
SN - 1179-2752
ER -
ID: 386573597